KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Precipio (PRPO) Asset Writedowns and Impairment (2016 - 2025)

Historic Asset Writedowns and Impairment for Precipio (PRPO) over the last 16 years, with Q3 2025 value amounting to $118000.0.

  • Precipio's Asset Writedowns and Impairment rose 6619.72% to $118000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$64000.0, marking a year-over-year decrease of 12831.86%. This contributed to the annual value of $64000.0 for FY2024, which is 7064.22% down from last year.
  • Per Precipio's latest filing, its Asset Writedowns and Impairment stood at $118000.0 for Q3 2025, which was up 6619.72% from -$25000.0 recorded in Q2 2025.
  • Precipio's Asset Writedowns and Impairment's 5-year high stood at $288000.0 during Q1 2021, with a 5-year trough of -$232000.0 in Q4 2021.
  • Over the past 5 years, Precipio's median Asset Writedowns and Impairment value was $51000.0 (recorded in 2023), while the average stood at $31210.5.
  • Data for Precipio's Asset Writedowns and Impairment shows a peak YoY increase of 59166.67% (in 2024) and a maximum YoY decrease of 37674.42% (in 2024) over the last 5 years.
  • Quarter analysis of 5 years shows Precipio's Asset Writedowns and Impairment stood at -$232000.0 in 2021, then skyrocketed by 169.4% to $161000.0 in 2022, then tumbled by 73.29% to $43000.0 in 2023, then tumbled by 376.74% to -$119000.0 in 2024, then skyrocketed by 199.16% to $118000.0 in 2025.
  • Its Asset Writedowns and Impairment was $118000.0 in Q3 2025, compared to -$25000.0 in Q2 2025 and -$38000.0 in Q1 2025.